National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 617826

History of Changes from the VAERS Wayback Machine

First Appeared on 1/14/2016

VAERS ID: 617826
VAERS Form:
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7 OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 0 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 0 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 0 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 9/14/2017

VAERS ID: 617826 Before After
VAERS Form:(blank) 1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 0 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 0 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 0 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 2/14/2018

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 6/14/2018

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 8/14/2018

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 9/14/2018

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 10/14/2018

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 12/24/2020

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 12/30/2020

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 5/7/2021

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


Changed on 5/14/2021

VAERS ID: 617826 Before After
VAERS Form:1
Age:11.0
Sex:Male
Location:Florida
Vaccinated:2016-01-05
Onset:2016-01-06
Submitted:2016-01-07
Entered:2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public      Purchased by: Public
Symptoms: Injection site cellulitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC 'Split Type':

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=617826&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166